Repligen Corporation (RGEN) Social Stream
REPLIGEN CORP (RGEN) Price Targets From Analysts
Use the tables below to see what analysts covering REPLIGEN CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 10 | $368 | $240 | $312.555 | $158.99 | 96.59% |
| 2021-12-20 | 10 | $368 | $240 | $315.888 | $158.99 | 98.68% |
| 2022-02-18 | 10 | $368 | $240 | $310.333 | $158.99 | 95.19% |
| 2022-03-01 | 10 | $368 | $210 | $281.444 | $158.99 | 77.02% |
| 2022-04-28 | 10 | $330 | $210 | $257.666 | $158.99 | 62.06% |
| 2022-06-01 | 9 | $330 | $170 | $249.888 | $158.99 | 57.17% |
| 2022-07-20 | 10 | $330 | $170 | $246.888 | $158.99 | 55.29% |
| 2022-08-03 | 10 | $330 | $170 | $248.555 | $158.99 | 56.33% |
| 2022-09-05 | 10 | $330 | $210 | $267.444 | $158.99 | 68.21% |
| 2022-10-23 | 7 | $320 | $210 | $257.125 | $158.99 | 61.72% |
| 2022-10-25 | 8 | $320 | $210 | $257.125 | $158.99 | 61.72% |
| 2022-11-01 | 7 | $320 | $210 | $254.625 | $158.99 | 60.15% |
| 2022-11-02 | 8 | $270 | $200 | $240.5 | $158.99 | 51.27% |
| 2022-12-07 | 9 | $270 | $190 | $232.111 | $158.99 | 45.99% |
| 2023-01-03 | 10 | $270 | $180 | $226.9 | $158.99 | 42.71% |
| 2023-02-02 | 10 | $270 | $180 | $223.9 | $158.99 | 40.83% |
| 2023-02-23 | 10 | $270 | $180 | $215.8 | $158.99 | 35.73% |
| 2023-03-06 | 10 | $250 | $180 | $213.8 | $158.99 | 34.47% |
| 2023-03-07 | 10 | $250 | $180 | $212.8 | $158.99 | 33.84% |
| 2023-04-20 | 11 | $250 | $180 | $214.363 | $158.99 | 34.83% |
| 2023-05-03 | 11 | $250 | $165 | $213 | $158.99 | 33.97% |
| 2023-06-01 | 11 | $240 | $157 | $199.272 | $158.99 | 25.34% |
| 2023-06-28 | 11 | $240 | $157 | $198.363 | $158.99 | 24.76% |
| 2023-07-06 | 11 | $240 | $156 | $198.272 | $158.99 | 24.71% |
| 2023-07-21 | 12 | $240 | $156 | $194.818 | $158.99 | 22.53% |
| 2023-08-01 | 11 | $240 | $156 | $194.818 | $158.99 | 22.53% |
| 2023-08-02 | 11 | $240 | $156 | $193 | $158.99 | 21.39% |
| 2023-08-04 | 11 | $240 | $156 | $193.909 | $158.99 | 21.96% |
| 2023-09-06 | 12 | $240 | $165 | $196.818 | $158.99 | 23.79% |
| 2023-09-13 | 12 | $240 | $165 | $196.454 | $158.99 | 23.56% |
| 2023-09-22 | 13 | $240 | $165 | $197.583 | $158.99 | 24.27% |
The Trend in the Analyst Price Target
Over the past 48 weeks, RGEN's average price target has gone down $59.54.
Over the past 48 weeks, RGEN's average upside potential has been 23.19%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-15 | 10 | 270 | 180 | 226.900 | 168.25 | 34.86% |
| 2023-07-31 | 11 | 240 | 156 | 194.818 | 171.56 | 13.56% |
| 2023-08-16 | 12 | 240 | 165 | 196.818 | 167.98 | 17.17% |
| 2023-09-15 | 13 | 240 | 165 | 197.583 | 165.50 | 19.39% |
| 2023-09-20 | 13 | 240 | 165 | 197.583 | 168.58 | 17.2% |
RGEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 10 | 1 | 2 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
RGEN's average broker recommendation rating worsened by 0.2 over the prior 41 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- REPLIGEN CORP's average analyst price target is higher than 3754.87% of all US stocks.
- REPLIGEN CORP's upside potential (average analyst target price relative to current price) is higher than 1054.98% of Pharmaceutical Products stocks.
- REPLIGEN CORP's number of analysts covering the stock is greater than 1160.11% of stocks in the large market cap category.
- REPLIGEN CORP's variance in analysts' estimates is lower than -1080.73% of Pharmaceutical Products stocks.
Stocks similar to REPLIGEN CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DNA, CGC, and TLRY.
View All Top Stocks by Price Target
What is the outlook for RGEN? Use POWR Ratings for clearer insight into price direction.